Vernal keratoconjunctivitis is a condition that usually presents in young children. It is one of the less common forms of allergic conjunctivitis, however, it arguably has some of the most significant and serious signs and symptoms. Victor Pegado, MD, described signs and how to handle these cases.
Screening and early diagnosis is very important for keratoconus patients. Two physicians discussed when to screen, what tests they use, and treatment options.
Demodex mites can cause a number of problems, including ocular issues. Several physicians discussed symptoms, what to look for, and ways to treat an infestation. Treatments in development were also discussed.
With more than 1 million new cases each year, herpes zoster is increasing in frequency. Two physicians discussed how to manage complications from herpes zoster, the vaccine for it, and treatment options.
Glaucoma Editor Nathan Radcliffe, MD, introduces the topics covered in the section, including early experience with Durysta, how other sustained therapies can benefit the glaucoma patient following cataract surgery, and how glaucoma care can be streamlined to keep everyone safe in the pandemic.
Newer steroid and NSAID options (and some off-label administration of antibiotics) that are delivered either via injection or intracanalicular insert can help avoid complicating a patient’s drop regimen that is already subject to non-compliance, instillation issues, potential for ocular surface agitation, and more.
Durysta, the sustained-release bimatoprost implant, 10 mcg (Allergan), has been available with FDA approval in the U.S. market for a year now. EyeWorld spoke with two physicians who started offering it as an option to their patients to hear about their experience thus far.
EyeWorld spoke with several glaucoma specialists who discussed changes they’ve noticed in glaucoma as well as in their own practices due to the COVID-19 pandemic. They shared how they’ve adapted to continue patient care and described the changes they think are here to stay post-pandemic.
This may not be the year that COVID-19 “goes away” but rather the year that we use what’s been learned to dig in for the next phase of a longer fight than was ever expected. But even in this still hunkering-down year, practices have to continue to pursue their development plans.
Developing a 2021 medical marketing strategy that is designed to meet the needs of patients in the COVID-19 era requires a change of mindset. Place yourself in patients’ shoes, start identifying relatable 2021 experiences, and convert those into profitable marketing opportunities, as well as chances to improve patient care.